These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23254420)

  • 41. Comparative Study of Activities of a Diverse Set of Antimycobacterial Agents against Mycobacterium tuberculosis and Mycobacterium ulcerans.
    Scherr N; Pluschke G; Panda M
    Antimicrob Agents Chemother; 2016 May; 60(5):3132-7. PubMed ID: 26883701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA.
    Lopez Quezada L; Silve S; Kelinske M; Liba A; Diaz Gonzalez C; Kotev M; Goullieux L; Sans S; Roubert C; Lagrange S; Bacqué E; Couturier C; Pellet A; Blanc I; Ferron M; Debu F; Li K; Aubé J; Roberts J; Little D; Ling Y; Zhang J; Gold B; Nathan C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
    Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
    Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors.
    Rogacki MK; Pitta E; Balabon O; Huss S; Lopez-Roman EM; Argyrou A; Blanco-Ruano D; Cacho M; Vande Velde CML; Augustyns K; Ballell L; Barros D; Bates RH; Cunningham F; Van der Veken P
    J Med Chem; 2018 Dec; 61(24):11221-11249. PubMed ID: 30500189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model.
    Sarkar S; Sarkar D
    J Biomol Screen; 2012 Aug; 17(7):966-73. PubMed ID: 22573731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
    Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
    ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy.
    Kozak SF; Inderlied CB; Hsu HY; Heller KB; Sadun AA
    Diagn Microbiol Infect Dis; 1998 Feb; 30(2):83-7. PubMed ID: 9554173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The virulence of resistant strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. I. The virulence of the resistant strains of Mycobacterium tuberculosis].
    Wang XG
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):204-6. PubMed ID: 6816557
    [No Abstract]   [Full Text] [Related]  

  • 51. NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G.
    Kidwai S; Bouzeyen R; Chakraborti S; Khare N; Das S; Priya Gosain T; Behura A; Meena CL; Dhiman R; Essafi M; Bajaj A; Saini DK; Srinivasan N; Mahajan D; Singh R
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimycobacterial activity of 9-sulfonylated/sulfenylated-6-mercaptopurine derivatives.
    Scozzafava A; Mastrolorenzo A; Supuran CT
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1675-8. PubMed ID: 11425535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis.
    Gupta A; Bhakta S
    J Antimicrob Chemother; 2012 Jun; 67(6):1380-91. PubMed ID: 22398649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9.
    Bottari B; Maccari R; Monforte F; Ottanà R; Rotondo E; Vigorita MG
    Bioorg Med Chem Lett; 2000 Apr; 10(7):657-60. PubMed ID: 10762047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis.
    Sarathy J; Dartois V; Dick T; Gengenbacher M
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1648-53. PubMed ID: 23335744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, characterization and pharmacological studies of copper complexes of flavone derivatives as potential anti-tuberculosis agents.
    Joseph J; Nagashri K; Suman A
    J Photochem Photobiol B; 2016 Sep; 162():125-145. PubMed ID: 27371912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.
    Hurdle JG; Lee RB; Budha NR; Carson EI; Qi J; Scherman MS; Cho SH; McNeil MR; Lenaerts AJ; Franzblau SG; Meibohm B; Lee RE
    J Antimicrob Chemother; 2008 Nov; 62(5):1037-45. PubMed ID: 18693235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting Phenotypically Tolerant Mycobacterium tuberculosis.
    Gold B; Nathan C
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28233509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis and antimycobacterial activity of some new pyridazine derivatives: bis-pyridazine. Part IV.
    Mantu D; Antoci V; Mangalagiu II
    Infect Disord Drug Targets; 2013 Oct; 13(5):344-51. PubMed ID: 24552228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.